CompletedPhase 3

Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population

France1,993 participantsStarted 2006-06-21

Plain-language summary

Randomized multicenter trial to assess the impact of a screening program for heavy alcohol drinkers and smokers treated in alcohol addiction clinics on upper aerodigestive tract cancer mortality.

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * current or previous heavy smokers (smoked \>= 20 years) and alcohol drinkers who need specialized care Exclusion Criteria: * Head and neck clinical examination during the past 6 months * History of squamous cell carcinoma of the upper aero-digestive tract. * Recent digestive hemorrhage from varicose esophagus

What they're measuring

Upper aerodigestive tract cancer mortality

Timeframe: 5 years

Trial details

NCT IDNCT00359645

SponsorGustave Roussy, Cancer Campus, Grand Paris

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-12-18

View on ClinicalTrials.gov More Pharynx Cancer trials